Latest Announcements

BSE & NSE corporate filings with AI summaries

BSECompany Update▲ PositiveExpansion7 Aug 2026

Pradeep Metals Ltd

Press release on the 43rd Annual General Meeting and an update on Setting up of Greenfield Manufacturing Facility at Butibori, Nagpur

Pradeep Metals Ltd reported strong FY26 performance, with total income of ₹33,030 lakh, EBITDA margin of 15.12%, profit after tax of ₹2,532 lakh and earnings per share of ₹14.67. The company announced a ₹250 crore investment to establish a greenfield manufacturing facility for large calibre ammunition in the Nagpur Defence Hub.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults7 Aug 2026

Sheela Foam Ltd

Transcript for the investor call held on August 05, 2026

Sheela Foam Ltd reported Q1 FY27 consolidated revenues of over INR1,000 crores and EBITDA of over INR100 crores, with a PAT of INR62 crores, a substantial jump year-on-year. The company's standalone Indian business delivered revenue growth of 20% and EBITDA growth of 13% on a year-on-year basis.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults7 Aug 2026

Ellenbarrie Industrial Gases Ltd

Ellenbarrie Industrial Gases Limited has informed the exchange regarding Investor Presentation for Earnings Conference Call scheduled on Monday, August 10, 2026 at 04:00 PM

Ellenbarrie Industrial Gases Ltd has announced its Q1 FY27 results, with revenue reaching ₹987 Mn, up 18% y-y and 13% q-q, driven by the ongoing ramp-up at Kurnool and Uluberia 2. EBITDA increased to ₹387 Mn, up 21% y-y and 50% q-q, with margins expanding to 39%. PAT increased 87% y-y and 53% q-q, supported by lower finance costs and lower effective tax rate.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults7 Aug 2026

Health X Platform Ltd

Please find attached the Investor Presentation of the Company

Health X Platform Ltd has released an investor presentation highlighting its revenue growth, expanding gross margin, and operating leverage. The company's capital allocation philosophy is based on Warren Buffett's discipline of real, capital-efficient earnings and Jeff Bezos's patience to reinvest in technology and infrastructure.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults7 Aug 2026

Titan Company Ltd

Titan Company Limited Performance Based Stock Unit Scheme 2026

Titan Company Limited has announced its Q1FY27 results, with a 40% growth in consolidated total income to ₹20,753 crores, and a 64% increase in profit before tax to ₹2,429 crores. The company has also approved the Titan Company Limited Performance Based Stock Unit Scheme 2026, subject to shareholder approval, and the appointment of Ms. Priya Mathilakath as the Chief People Officer.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults7 Aug 2026

Ellenbarrie Industrial Gases Ltd

Ellenbarrie Industrial Gases Limited has informed the exchanged regarding Press release on the Unaudited Financial Results of the Company for the quarter ended June 30, 2026.

Ellenbarrie Industrial Gases Ltd has announced its unaudited financial results for Q1 FY27, with revenue from operations increasing 18% YoY and 13% QoQ to ₹987 million, EBITDA rising 21% YoY and 50% QoQ to ₹387 million, and PAT nearly doubling to ₹350 million.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults7 Aug 2026

Cupid Ltd-$

Press Release - Q1 FY27 Financial Results

Cupid Ltd reported strong Q1 FY27 performance with 159% YoY operating income growth and 194% YoY net profit growth. The company upgraded its FY27 guidance to ₹725 Cr – ₹750 Cr revenue and ₹210 Cr - ₹225 Cr net profit.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults7 Aug 2026

Asarfi Hospital Ltd

Intimation Under Regulation 30 of the SEBI (Listing obligation and Disclosure Requirements) Regulations, 2015- Submission of Press Release/ Media Release.

Asarfi Hospital Ltd has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, showing a 33% YoY revenue growth to ₹4,734 Lakhs, with EBITDA margin at 20% and PAT margin at 9%. The company's operational momentum across units is driven by growth in patient volumes and higher realizations, with ARPOB increased to ₹23,498 (Super-Specialty) and ₹31,892 (Cancer Unit).

Read more →📎 1 attachment
← PreviousPage 300 of 438Next →